Name: Aytu BioPharma, Inc. (AYTU) Balance Sheet
Creator: FinSpry

Aytu BioPharma Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Aytu BioPharma, Inc. (AYTU) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2019	FY 2018
Period Ending	Dec 2025	Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2019	Jun 2018
Current Assets
Cash and Cash Equivalents	30.95	20.01	22.99	19.36	49.65	11.04	7.01
Cash & Short-Term Investments	30.95	20.01	22.99	19.36	49.65	11.04	7.01
Accounts Receivable	31.16	23.53	28.73	21.71	28.18	1.74	0.58
Inventory	11.43	12.14	8.51	10.85	16.34	1.44	1.34
Other Current Assets	5.64	5.10	5.43	0.63	9.78	0.00	0.00
Total Current Assets	79.18	61.89	71.08	59.93	105.23	15.43	9.47
Non-Current Assets
Property, Plant & Equipment (Net)	1.59	1.52	3.61	6.30	8.70	0.41	0.22
Goodwill	0.00	0.00	0.00	0.00	65.80	0.00	0.00
Intangible Assets	42.20	52.45	57.44	70.63	85.46	0.00	0.00
Other Non-Current Assets	1.20	1.47	2.96	0.77	0.47	-0.20	0.00
Total Non-Current Assets	45.00	56.20	65.38	77.69	160.43	19.29	11.59
Total Assets	124.18	118.10	136.46	137.62	265.67	34.72	21.06
Current Liabilities
Accounts Payable	10.60	10.31	12.55	55.17	19.26	3.35	2.31
Short-Term Debt	11.06	1.86	1.65	3.91	16.57	0.00	0.00
Current Portion of Long-Term Debt	1.86	1.86	0.00	0.00	16.57	0.00	0.00
Accrued Liabilities	28.22	22.26	24.54	33.65	30.72	0.00	0.00
Other Current Liabilities	41.41	24.69	29.02	5.36	34.86	1.08	0.55
Total Current Liabilities	63.06	62.23	69.02	64.44	109.44	5.37	3.39
Non-Current Liabilities
Long-Term Debt	11.88	10.88	14.71	14.28	0.18	0.00	0.00
Deferred Tax Liabilities	0.00	0.76	1.38	0.00	0.00	0.00	0.00
Other Non-Current Liabilities	30.27	15.94	11.17	12.80	18.48	22.25	4.15
Total Non-Current Liabilities	42.15	28.15	28.09	28.87	18.66	22.26	4.24
Total Liabilities	105.21	90.38	97.11	93.32	128.10	27.63	7.64
Stockholders' Equity
Common Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Retained Earnings	-333.54	-319.97	-304.13	-287.08	-178.30	-106.39	-79.26
Additional Paid-in Capital	352.50	347.69	343.49	331.39	315.86	113.48	92.68
Shares Outstanding	8.98	5.97	5.52	1.93	0.00	0.00	0.00
Total Stockholders' Equity	18.97	27.72	39.36	44.31	137.57	7.09	13.42
Total Liabilities & Equity	124.18	118.10	136.46	137.62	265.67	34.72	21.06